Why did VIMTALABS.NS stock drop so sharply on 29 Jan 2026?

The drop followed the company’s earnings timing and investor reaction to guidance and headline metrics. Heavy volume (696,807) and relative underperformance versus sector averages triggered stop-losses and short-term selling pressure.

What are key valuation metrics for VIMTALABS.NS?

Vimta trades at a PE of **27.50**, PB of **4.90**, EPS **INR 16.60**, and price-to-sales around **5.31**. These show a premium versus many diagnostics peers and leave room for valuation compression if growth slows.

What price levels should investors watch for VIMTALABS.NS forecast and trading?

Watch near-term support at **INR 420.00** and **INR 400.30** (year low). Resistance and recovery hurdles include the 50-day average **INR 592.85** and model monthly target **INR 635.61**. Use stop limits and position sizing.

How does Meyka AI view VIMTALABS.NS stock?

Meyka AI rates VIMTALABS.NS **75.31 / B+ (BUY)** based on benchmarks, sector performance, growth and metrics. The forecast model projects a yearly **INR 626.99**, but forecasts are projections and not guarantees.

IN Stocks

VIMTALABS.NS falls 16.99% on 29 Jan 2026 (NSE): watch valuation levels

ByDanny Kontos January 29, 2026

We saw a sharp drop in VIMTALABS.NS stock on 29 Jan 2026 after the stock closed down 16.99% to INR 422.55 on the NSE in India. Trading volume jumped to 696,807 shares versus a 50-day average of 197,230, signalling heavy selling on the session close. The move follows the company’s recent earnings release and left the stock trading well below its 50-day average of INR 592.85, raising questions about near-term support and valuation for Vimta Labs Limited